Guidant LLC v. Comm'r
This text of 146 T.C. No. 5 (Guidant LLC v. Comm'r) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
An appropriate order will be issued.
Ps are a group of U.S. corporations which filed consolidated Federal income tax returns for the subject years. During those years Ps, primarily through the group's U.S. subsidiaries, consummated transactions with their foreign affiliates. The transactions included the licensing of intangibles, the purchase and sale of manufactured property, and services. R, relying upon his authority under
*61 LARO,
| 1997 | $4,958,493 |
| 2000 | 11,453,096 |
| 2001 | 214,674,105 |
| 2002 | 220,769,960 |
| 2003 | $73,237,038 |
| 1999 |
| 1997 | $4,958,493 |
| 2000 | 11,453,096 |
| 2001 | 214,674,105 |
| 2002 | 220,769,960 |
| 2003 | $73,237,038 |
| 1999 | $240,837,494 |
| 2006 | $117,437,929 |
| 2007 | 36,611,782 |
*62
| 1995 | $4,128,012 |
| Accuracy-related penalty | ||
| 2004 | $107,238,205 | -0- |
| 2005 | 16,168,621 | -0- |
| 4/21/2006 | 453,283,060*6 | $41,109,080 |
The deficiencies and the accuracy-related penalty flow from respondent's transfer pricing adjustments under
Petitioners move for partial summary judgment, asserting that respondent's adjustments are arbitrary,*7 capricious, and unreasonable as a matter of law. Such is so, petitioners argue, because (1) respondent did not determine the "true separate taxable income" of each controlled taxpayer in the Guidant group as required by
The parties argued their respective positions at a hearing held in New York, New York. We now decide whether to grant the motion. We will deny it. We hold as to petitioners' former argument that neither
We have derived the recitations listed in this background section primarily from the undisputed portions of each party's statement of the facts, as drawn from the pleadings and other acceptable materials. We also have derived some of the recitations from the disputed portions of each party's statement of the facts, as viewed in a manner most favorable to respondent, the party opposing petitioners' motion for partial summary judgment. We set forth all recitations solely for purposes of deciding petitioners' motion and not as findings of fact.
Guidant Corp. is a U.S. corporation that from 2001 through 2006 was the parent of an affiliated group that included its U.S. subsidiaries Cardiac Pacemakers, Inc. (CPI), CardioThoracic Systems, Inc. (CTS), Guidant Sales*9 *64 Corp. (GSC) , Advanced Cardiovascular Systems, Inc. (ACS), and Endovascular Technologies, Inc. (EVT). Boston Scientific Corp. (BSC) acquired Guidant Corp. on April 21, 2006. Guidant Corp. and each of its U.S. subsidiaries were thereafter separate members of the affiliated group of which BSC was the parent. Guidant Corp. remained the parent of its remaining subsidiaries for which it had been the parent before BSC acquired Guidant Corp.
Guidant Corp. and its U.S. and foreign business entities (collectively, subsidiaries) developed, manufactured, and sold medical devices. Guidant Corp. and its subsidiaries conducted business throughout the developed world.
For each subject year Guidant Corps.'s first-tier U.S. subsidiaries included CPI and CTS, and Guidant Corp.'s second-tier U.S. subsidiaries included GSC. From 2001 through 2006 Guidant Corp.'s first-tier U.S. subsidiaries also included ACS and EVT.
Guidant Corp.'s first-, second-, and third-tier foreign subsidiaries included two Netherlands corporations, Guidant BV (renamed Guidant Group BV in 2003) and Guidant Puerto Rico BV, and one Luxembourg corporation, Guidant Luxembourg SARL. Guidant Puerto Rico BV and Guidant Luxembourg*10 SARL were subsidiaries of Guidant BV.
Guidant Luxembourg SARL owned and operated a manufacturing facility through a branch, Guidant Ireland, established in Ireland. Guidant Puerto Rico BV owned and operated a manufacturing facility through a branch, Guidant Puerto Rico, established in Puerto Rico. Guidant Corp. provided administrative services to Guidant Ireland and to Guidant Puerto Rico.
The Guidant group consisted of various business units operated by separate corporations. From 2001 through April 21, 2006, these business units were Cardiac Rhythm Management (CRM), Endovascular Solutions (ES), Vascular Intervention (VI), and Cardiac Surgery (CS). On April 21, *65 2006, the Guidant group sold its VI and ES business units. Thereafter, the Guidant group consisted of the CRM and the CS business units.
CRM devices included pulse generators (PGs) (e.g., pacemakers, implantable cardiac defibrillators, and cardiac resynchronization devices) and leads.
CPI operated the CRM business unit during all subject years.
ES devices included an aortic vascular prosthesis (Ancure) that could be delivered via balloon catheter to treat aortic aneurysms.*11
EVT operated the ES business unit from 2001 through part of 2003. Guidant Endovascular Solutions, Inc. (GES), a U.S. corporation, assumed EVT's operations on January 1, 2004. GES did not participate in any of the controlled transactions at issue.
VI devices included balloon catheters used in angioplasty procedures, coronary stents and their delivery systems, and guidewires used to direct balloon catheters and stent delivery systems to the area of treatment.
ACS operated the VI business unit during 2001 through 2006.
CS devices included devices used to harvest femoral arteries from a patient for use in coronary artery bypass grafting surgery (Vasoview), off-pump coronary artery bypass (OPCAB) systems, and cardiac ablation devices.
CTS operated the CS business unit during all subject years.
Guidant Ireland manufactured PGs during all subject years. Each PG contained a "hybrid," which is an electric circuit *66 board to which integrated circuits and other electronic components are bonded.
Before 2004 Guidant Ireland purchased from CPI all of the hybrids that were incorporated into the PGs it manufactured.*12 Guidant Ireland began manufacturing hybrids in 2004. From 2004 through 2007 Guidant Ireland manufactured PGs using both hybrids it manufactured and hybrids purchased from CPI.
From 2001 until the Guidant group sold the VI business, Guidant Ireland manufactured VI coronary stents and coronary stent delivery systems. From 2005 until that sales date, Guidant Ireland also manufactured VI standalone balloon catheters for use in angioplasty procedures.
Guidant Puerto Rico manufactured CRM leads and CS Vasoview devices during all subject years. During 2002 and part of 2003, Guidant Puerto Rico also manufactured ES Ancure devices. From 2002 until the Guidant group sold its VI business, Guidant Puerto Rico also manufactured VI guidewires. From 2004 through the end of the subject years, Guidant Puerto Rico also manufactured CS cardiac ablation devices. During 2007 Guidant Puerto Rico also manufactured CS OPCAB systems.
GSC was the Guidant group's U.S. marketing and sales affiliate. GSC sold and distributed to end users in the U.S. devices that Guidant Ireland or Guidant Puerto Rico manufactured.
Foreign Guidant Corp. distribution subsidiaries (Guidant foreign*13 sales affiliates) sold in many countries outside of the U.S. devices that Guidant Corp. and its subsidiaries manufactured. In a foreign market with a Guidant foreign sales affiliate, that affiliate sold and distributed to end users in its market devices that Guidant Ireland or Guidant Puerto Rico manufactured. In foreign markets without a Guidant foreign sales affiliate, independent third-party foreign distributors sold and distributed to end users devices that Guidant Corp. and its subsidiaries manufactured.
CPI owned intangible property related to CRM PGs and hybrids that it licensed to Guidant Ireland in exchange for royalties.
CPI manufactured and sold CRM hybrids to Guidant Ireland. Guidant Ireland sold finished CRM devices to GSC and to CPI. CPI resold the Guidant Ireland CRM devices it purchased to independent third-party foreign distributors. Guidant Ireland also sold finished CRM devices directly to Guidant foreign sales affiliates and to independent third-party foreign distributors.
CPI owned intangible property*14 related to CRM leads that it licensed to Guidant Puerto Rico in exchange for royalties.
Guidant Puerto Rico sold CRM leads it manufactured to GSC and to CPI. CPI resold the Guidant Puerto Rico leads it purchased to the Guidant foreign sales affiliates and to independent third-party foreign distributors. Guidant Puerto Rico also sold CRM leads it manufactured to Guidant Ireland. Guidant Ireland resold the Guidant Puerto Rico leads it purchased to the Guidant foreign sales affiliates and to the independent third-party foreign distributors.
ACS owned intangible property related to VI stents, stent delivery systems, and angioplasty balloon catheters that it licensed to Guidant Ireland. Guidant Ireland paid ACS royalties in exchange for that license.
Before Guidant Ireland gained VI product sterilization capabilities in 2004, Guidant Ireland sold all of the VI devices it manufactured to ACS. ACS sterilized the Guidant Ireland VI devices it purchased in return for a sterilization fee. ACS resold the Guidant Ireland VI devices it purchased and sterilized to GSC, to the Guidant foreign sales affiliates, and to the independent third-party foreign distributors.
After*15 Guidant Ireland gained VI product sterilization capabilities in 2004, Guidant Ireland continued selling its VI devices intended for the U.S. market to ACS. ACS continued to resell these devices to GSC. After Guidant Ireland gained *68 VI product sterilization capabilities in 2004, Guidant Ireland also sold its VI devices intended for foreign markets to the Guidant foreign sales affiliates and to the independent third-party foreign distributors.
ACS owned intangible property related to VI guidewires that it licensed to Guidant Puerto Rico. Guidant Puerto Rico paid ACS royalties in exchange for that license.
Guidant Puerto Rico sold all of the VI devices it manufactured to ACS. ACS sterilized the Guidant Puerto Rico VI devices it purchased in return for a sterilization fee. ACS resold the Guidant Puerto Rico VI devices it purchased to GSC, to the Guidant foreign sales affiliates, and to the independent third-party foreign distributors.
EVT owned intangible property related to ES Ancure devices that it licensed to Guidant Puerto Rico. Guidant Puerto Rico paid EVT royalties in exchange for that license.
Guidant Puerto Rico sold*16 all of the ES devices it manufactured to EVT. EVT resold the Guidant Puerto Rico ES devices it purchased to GSC, to the Guidant foreign sales affiliates, and to the independent third-party foreign distributors.
CTS owned intangible property related to CS Vasoview devices, OPCAB systems, and cardiac ablation devices that it licensed to Guidant Puerto Rico. Guidant Puerto Rico paid CTS royalties in exchange for that license.
Guidant Puerto Rico sold all of the CS devices it manufactured to CTS. CTS resold the Guidant Puerto RicoCS devices it purchased to GSC, to the Guidant foreign sales affiliates, and to the independent third-party foreign distributors.
Respondent audited the consolidated Federal income tax returns that the Guidant group filed for 2001 through April 21, 2006, and the consolidated Federal income tax returns that BSC and its U.S. subsidiaries (BSC group) filed for 2006 and 2007. During the audits respondent considered, as to the *69 years ended on or before April 21, 2006, whether income was allocated properly between the Guidant group and their foreign affiliates; and as to 2006 and 2007, whether income was allocated properly between*17 the BSC group and their foreign affiliates. Respondent considered whether the transfer of intangible property, the sale of components and finished goods, and the provision of services with respect to certain products (collectively, transactions at issue) were made at arm's length. For each subject year, the transactions at issue involved Guidant Corp., CPI, CTS, and GSC. The transactions at issue also involved ACS for 2001 through April 2006 and EVT for 2001 through 2003.
To evaluate whether income was allocated at arm's length between the Guidant group and their foreign affiliates, respondent considered petitioners' transfer pricing studies, as well as financial data and other information made available by petitioners and that was publicly available. In connection with the audit for 2006 and 2007, respondent also considered the methodologies and approaches taken with respect to the audit for the 2001 through April 2006 examination cycles. Respondent concluded that income was not allocated at arm's length between the Guidant group and their foreign affiliates and adjusted Guidant Corp.'s STI for each subject year to effect a pro tanto adjustment to the groups' CTI for those years. Respondent*18 did not compute specific adjustments for each controlled taxpayer included in the group (member-specific adjustments). The IRS' practice is to compute member-specific adjustments when the taxpayer and the audit team can agree on such adjustments or when the audit team has sufficient information to make them. The IRS' practice is to defer making member-specific adjustments in other circumstances until a final resolution has been reached because these determinations often involve complex calculations, as well as extensive and collaborative discussions with the taxpayer. Because the parties did not reach a resolution of the
Respondent did not believe that he could independently make reliable member-specific adjustments on the basis of the information available to him. Respondent considered the complexity of the activities of each member of the Guidant *70 group and its relationship with the activities of other members of the Guidant group and/or of their foreign affiliates. Respondent also concluded that he could not independently make reliable member-specific*19 adjustments for each of the Guidant group members after considering the flow of products among Guidant group entities, involving multiple steps and multiple transfer pricing transactions. For many products, the flow involved a "round trip" from the United States to Ireland or to Puerto Rico and back.
Each Guidant group member's available financial statements encompassed all activities the entity performed and all products produced and sold, including those not at issue in these cases. Respondent was unable to extract the information necessary to ascertain the income reported by each Guidant group member with respect to the products and transactions at issue and to determine the STI of each Guidant group member for the products and transactions at issue. Petitioners did not maintain their financial records in a manner that allowed them to readily track income and expenses by place of manufacture, and petitioners could not tie the income and expenses in the business unit financial statements to particular product lines, e.g., pulse generators or leads, or to products manufactured in the United States, in Ireland, or in Puerto Rico.
An example of the information that respondent needed to*20 determine the income reported by each Guidant group member with respect to the products manufactured in Ireland and in Puerto Rico was the transfer prices paid by each Guidant group member. For the VI business, ACS purchased finished products from Guidant Ireland and Guidant Puerto Rico at a set transfer price. ACS then either resold these products to GSC or to Guidant group foreign distribution affiliates at a different transfer price or sold these products to an independent foreign distributor at a final sale price. Respondent did not have the transfer prices for any of these transactions so as to determine the profit reported by each Guidant group member for the products at issue. While the available information enabled respondent to make what he considered a reliable calculation of CTI for the Guidant group, he did not believe the available information enabled him to make a sufficiently reliable calculation of member-specific adjustments for each of the Guidant group members.
The deficiency notice for 2001 and 2002 described the It is determined under It is determined under
The deficiency notice for 2004 through April 2006 described the It is determined under
That notice did not calculate or specify what, if any, amount of the
The deficiency notice for 2006 and 2007 described the It is determined under
The Commissioner may "distribute, apportion, or allocate gross income, deductions, credits, or allowances between or among * * * [controlled enterprises], if he determines that such distribution, apportionment, or allocation is necessary in order to prevent evasion of taxes or clearly to reflect the income of any such [enterprises]".
The Commissioner's authority to adjust items under
Petitioners' motion for partial summary judgment addresses the first hurdle, specifically the issue of whether respondent abused his discretion. Petitioners argue primarily that respondent abused his discretion because he failed to determine the true STI of each controlled taxpayer that engaged in the adjusted transactions. As petitioners see it,
Petitioners argue secondarily that respondent abused his discretion because he failed to make a
Either party may move for summary judgment on all or some of the legal issues in dispute.
Petitioners argue primarily that respondent's adjustments are arbitrary, capricious, and unreasonable as a matter of law because respondent did not determine the "true*28 separate taxable income" of each controlled taxpayer within the meaning of (iv) Consolidated returns.--
We construe the meaning of regulatory text using rules similar to the rules which we use to construe statutory text.*29
We first turn to the plain language of
We thus turn to the meaning of the words "consistently with the principles of a consolidated return" in
Four score and three years ago, the U.S. Supreme Court stated in the setting of two corporations desiring to file a consolidated return that "[t]he requirement of consolidated returns*31 was 'based upon the principle of levying the tax according to the true net income and invested capital of a single business enterprise, even though the business is operated through more than one corporation.'"
Further, interpretation of the consolidated return*32 regulations by this Court reveals that "[t]he purpose of the consolidated return regulations is to provide rules so that the tax liability of a consolidated group will be clearly reflected and to prevent an avoidance of such tax liability."
We recognize that the consolidated return regulations state that the computation of CTI begins with a determination of each group member's STI.
Yet we are also mindful that the term "true separate taxable income" is somewhat of a misnomer in that the true STI of a controlled taxpayer is not actually that taxpayer's taxable *78 income which would be taxed were the taxpayer to have filed a separate tax return. Instead, STI*33 serves as a recapitulation of each member's taxable items in accordance with the provisions of the Code, as possibly adjusted to reflect certain modifications and exclusions.
Bearing the principles of the consolidated return regime in mind, we read
Consistent with the IRS practice on this matter,
Our reading of
On the basis of the record before us, which we must construe favorably to respondent as the party opposing the motion for partial summary judgment, respondent's revenue agents concluded that they were unable to make reliable member-specific adjustments on the basis of the available information. The agents reached their conclusion, in part, on the basis of the relationships between the Guidant group members*36 and their foreign affiliates and on the alleged lack of documentation to make reliable adjustments. Each of petitioners' entities, including CPI, ACS, EVT, and CTS, performed numerous functions on behalf of its business unit and performed functions on behalf of other Guidant-group-related entities, including Guidant Ireland, Guidant Puerto Rico, GSC, and Guidant's sales affiliates. In addition, the Guidant group members each owned valuable intangibles relating to the development and manufacture of the products within their business units, and many products were manufactured *80 both by a Guidant group member and by Guidant Ireland or Guidant Puerto Rico.
Petitioners allege that they maintained all the necessary information and records to make the STI determinations, but it would be too costly or otherwise difficult for respondent to extract that information at the time of the audit from petitioners' accounting databases. Whether respondent's decision to delay the STI computations constitutes abuse of discretion under these circumstances is thus still in dispute and remains to be determined on the full record of the case as developed at trial.
For the reasons stated above, we will deny petitioners'*37 motion to the extent of their primary argument.
Petitioners argue secondarily that respondent's (b) Arm's length standard.--(1) In general.--In determining the true taxable income of a controlled taxpayer, the standard to be applied in every case is that of a taxpayer dealing at arm's length with an uncontrolled taxpayer. A controlled transaction meets the arm's length *81 standard if the results of that transaction are consistent with the results that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances (arm's length result). * * * (2) Arm's length methods.--(i) Methods.— * * * (ii) Selection of category of method applicable to transaction.-- The methods listed in * * * * (f) Scope of review.-- * * * (2) Rules relating to determination of true taxable income.-- The following rules must be taken into account in determining the true taxable income of a controlled taxpayer. (i) Aggregation of transactions.--(A) In general.--The combined effect of two or more separate transactions (whether before, during, or after the taxable year under review) may be considered, if such transactions, taken as a whole, are so interrelated that consideration of multiple transactions is the most reliable means of determining the arm's length consideration for the controlled transactions. Generally, transactions will be aggregated only when they involve related products or services, as defined in * * **40 * (iv) Product lines and statistical techniques.--The methods described in
As we have discussed,
Notwithstanding the strength of the regulations, petitioners argue that the Commissioner may not aggregate separate transactions involving tangibles, intangibles, or services. We disagree. The regulations let the Commissioner aggregate separate transactions involving tangibles, intangibles, or services when doing so provides the best means of determining the true taxable income of a controlled taxpayer.
*83 The ability to aggregate transactions involving transfers of tangible property, transfers of intangible property, and provision of services is further confirmed by
In closing on this issue, we will deny petitioners' motion to the extent of their secondary argument.4The transfer pricing regulations permit the Commissioner to aggregate interrelated transactions when doing so would produce "the most reliable means of determining the arm's length consideration for the controlled transactions."
We will deny petitioners' motion for partial summary judgment. We have considered all arguments that the parties made, and to the extent not discussed above, conclude that those arguments not discussed herein are irrelevant, moot, or without merit. To reflect the foregoing,
Footnotes
1. The following cases are consolidated herewith: Cardiac Pacemakers, Inc., as substitute agent for the Guidant Consolidated Group, docket No. 5990-11; Cardiac Pacemeakers, Inc., as successor by merger to CPI Del Caribe, Ltd., docket No. 10985-11; Boston Scientific Corp. & Subs., docket No. 26876-11; Guidant, LLC f.k.a. Guidant Corporation and Subsidiaries, docket No. 5501-12; and Cardiac Pacemakers, Inc., as substitute agent for Guidant Consolidated Group, docket No. 5502-12.↩
2. Unless otherwise indicated, section references are to the Internal Revenue Code (Code) applicable to the years at issue, and Rule references are to the Tax Court Rules of Practice and Procedure.↩
3.
Sec. 1.6038A-3(c)(7)(vii), Income Tax Regs.↩ , states: "The term "related products or services" means groupings of products and types of services that reflect reasonable accounting, marketing, or other business practices within the industries in which the related party group operates."4. Petitioners also argue that the setoff rules and certain penalty provisions may not be applied appropriately if adjustments are not made by transaction types. We are unpersuaded by these arguments for reasons already discussed.↩
Related
Cite This Page — Counsel Stack
146 T.C. No. 5, 146 T.C. 60, 2016 U.S. Tax Ct. LEXIS 5, Counsel Stack Legal Research, https://law.counselstack.com/opinion/guidant-llc-v-commr-tax-2016.